Immune to Cancer: The CRI Blog
-
CICON15 Report from Day 2
Highlights from Day 2 of the inaugural International Cancer Immunotherapy Conference.
-
CICON15 Report from Day 1
Highlights from Day 1 of the inaugural International Cancer Immunotherapy Conference.
-
CRI to Co-Host Inaugural International Cancer Immunotherapy Conference
The 4-day “go-to” meeting for scientists, clinicians, regulators, drug developers, and patient advocates begins this week.
-
CRI Member to Chair Immuno-Oncology 360 Conference
Dr. Axel Hoos, a member of the CRI Scientific Advisory Council, will chair and be the keynote…
-
What Cancer Patients Should Know: Latest Immunotherapy News from ASCO
Learn the latest news in cancer immunotherapy for melanoma, lung cancer, leukemia, liver cancer, and other cancer…
-
ASCO 2015: Report from Day 5
The last day of the ASCO meeting featured talks on immunotherapy for pancreatic cancer, one the deadliest…
-
ASCO 2015: Report from Day 4
More cancers prove treatable with checkpoint blockade therapy. Today: kidney, bladder, and ovarian cancer.
-
ASCO 2015: Report from Day 3
Immunotherapy for brain cancer and the results of a large clinical trial for patients with advanced melanoma.
-
ASCO 2015: Report from Day 2
The latest results from clinical trials of checkpoint inhibitors for lung cancer, liver cancer, and more.